INSMED Inc (INSM)

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Address

700 US HIGHWAY 202/206
BRIDGEWATER, NJ 08807

Founded

1988

Number of Employees

912

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)